Inhibition of Myostatin Signaling through Notch Activation following Acute Resistance Exercise
Open Access
- 2 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e68743
Abstract
Myostatin is a TGFβ family member and negative regulator of muscle size. Due to the complexity of the molecular pathway between myostatin mRNA/protein and changes in transcription, it has been difficult to understand whether myostatin plays a role in resistance exercise-induced skeletal muscle hypertrophy. To circumvent this problem, we determined the expression of a unique myostatin target gene, Mighty, following resistance exercise. Mighty mRNA increased by 6 h (82.9±24.21%) and remained high out to 48 h (56.5±19.67%) after resistance exercise. Further examination of the soleus, plantaris and tibialis anterior muscles showed that the change in Mighty mRNA at 6 h correlated with the increase in muscle size associated with this protocol (R2 = 0.9996). The increase in Mighty mRNA occurred both independent of Smad2 phosphorylation and in spite of an increase in myostatin mRNA (341.8±147.14% at 3 h). The myostatin inhibitor SKI remained unchanged. However, activated Notch, another potential inhibitor of TGFβ signaling, increased immediately following resistance exercise (83±11.2%) and stayed elevated out to 6 h (78±16.6%). Electroportion of the Notch intracellular domain into the tibialis anterior resulted in an increase in Mighty mRNA (63±13.4%) that was equivalent to the canonical Notch target HES-1 (94.4±7.32%). These data suggest that acute resistance exercise decreases myostatin signaling through the activation of the TGFβ inhibitor Notch resulting in a decrease in myostatin transcriptional activity that correlates well with muscle hypertrophy.Keywords
This publication has 37 references indexed in Scilit:
- Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell DysfunctionPLOS ONE, 2013
- Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: Potential role of follistatin in mediating testosterone actionMolecular and Cellular Endocrinology, 2012
- Role of Notch and its oncogenic signaling crosstalk in breast cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular DystrophyThe American Journal of Pathology, 2011
- Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic MicePLOS ONE, 2010
- Testosterone Supplementation Reverses Sarcopenia in Aging through Regulation of Myostatin, c-Jun NH2-Terminal Kinase, Notch, and Akt Signaling PathwaysEndocrinology, 2010
- Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Mighty is a novel promyogenic factor in skeletal myogenesisExperimental Cell Research, 2008
- Repression of Activator Protein-1-mediated Transcriptional Activation by the Notch-1 Intracellular DomainJournal of Biological Chemistry, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001